UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
__________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 24, 2011
|
The Female Health Company
|
|
(Exact name of registrant as specified in its charter)
|
|
Wisconsin
|
1-13602
|
39-1144397
|
||
|
(State or other jurisdiction
of incorporation)
|
(Commission File Number)
|
(IRS Employer
Identification No.)
|
|
515 North State Street, Suite 2225, Chicago, Illinois 60654
|
|
(Address of principal executive offices, including zip code)
|
|
(312) 595-9123
|
|
(Registrant's telephone number, including area code)
|
|
Not Applicable
|
|
(Former name or former address, if changed since last report)
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| o |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
| o |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
| o |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
| o |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Section 5 – Corporate Governance and Management
Item 5.07. Submission of Matters to a Vote of Security Holders.
The Annual Meeting of Shareholders of The Female Health Company (the "Company") was held on March 24, 2011. A total of 27,741,424 shares of common stock were eligible to vote at the Annual Meeting. The matters voted on at the Annual Meeting were as follows:
1. Election of Directors:
The following individuals were nominated for election to the Board of Directors for terms that expire at the next annual meeting of shareholders.
|
Name
|
Votes
For
|
Votes
Withheld
|
Broker
Non-Votes
|
|||
|
David R. Bethune
|
11,119,843
|
217,232
|
9,338,949
|
|||
|
Stephen M. Dearholt
|
11,129,371
|
207,704
|
9,338,949
|
|||
|
Mary M. Frank, Ph.D.
|
11,140,583
|
196,492
|
9,338,949
|
|||
|
William R. Gargiulo, Jr.
|
11,107,126
|
229,949
|
9,338,949
|
|||
|
Mary Ann Leeper, Ph.D.
|
10,820,493
|
516,582
|
9,338,949
|
|||
|
O.B. Parrish
|
11,167,435
|
169,640
|
9,338,949
|
|||
|
Michael R. Walton
|
11,123,244
|
213,831
|
9,338,949
|
|||
|
Richard E. Wenninger
|
11,126,023
|
211,052
|
9,338,949
|
The nominations were made by the Board of Directors and no other nominations were made by any shareholder. The nominees had currently been members of the Board of Directors at the date of the Annual Meeting.
2. Ratification of Auditors:
The shareholders voted to ratify the appointment by the Company's Audit Committee of McGladrey & Pullen, LLP as the Company's independent registered public accounting firm for the fiscal year ending September 30, 2011.
|
Votes For
|
Votes Against
|
Abstentions
|
Broker Non-Votes
|
|||
|
20,516,323
|
104,602
|
55,099
|
-
|
3. Advisory (non-binding) vote on the executive compensation of the Company's named executive officers:
The shareholders voted in favor of the compensation of the Company's named executive officers as disclosed in the proxy statement for the Annual Meeting of Shareholders.
|
Votes For
|
Votes Against
|
Abstentions
|
Broker Non-Votes
|
|||
|
11,081,787
|
177,224
|
78,064
|
9,338,949
|
2
4. Advisory (non-binding) vote on the frequency of the advisory vote on the executive compensation of the Company's named executive officers:
The shareholders voted to recommend that the Company include an advisory vote on the compensation of the Company's named executive officers pursuant to the rules of the Securities and Exchange Commission every three years.
|
One Year
|
Two Years
|
Three Years
|
Abstentions
|
Broker Non-Votes
|
||||
|
3,365,113
|
269,299
|
7,663,868
|
38,795
|
9,338,949
|
3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
THE FEMALE HEALTH COMPANY
Date: March 28, 2011
BY /s/ O.B. Parrish
O.B. Parrish, Chairman and
Chief Executive Officer
4